MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug hope for rare Muscle-Weakening disease
Disease control OngoingThis study tests an investigational drug called efgartigimod given through a vein for adults with generalized myasthenia gravis (gMG) who do not have the usual acetylcholine receptor antibody. The goal is to see if it improves daily activities and muscle strength compared to a pl…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
New drug trial aims to ease muscle weakness in myasthenia gravis
Disease control OngoingThis study tests an experimental drug called DNTH103 in 65 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo to see if it safely improves daily activities like talking, swallowing, and breathing. The …
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC